Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
5.86
+0.57 (10.78%)
At close: Aug 13, 2025, 4:00 PM
5.58
-0.28 (-4.78%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 28 employees as of December 31, 2024. The number of employees decreased by 13 or -31.71% compared to the previous year.
Employees
28
Change (1Y)
-13
Growth (1Y)
-31.71%
Revenue / Employee
n/a
Profits / Employee
-$709,000
Market Cap
17.74M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | -13 | -31.71% |
| Dec 31, 2023 | 41 | 3 | 7.89% |
| Dec 31, 2022 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CLDI News
- 5 days ago - Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewsWire
- 19 days ago - Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025 - GlobeNewsWire
- 23 days ago - Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24 - GlobeNewsWire
- 5 weeks ago - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment - GlobeNewsWire
- 5 weeks ago - Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds - GlobeNewsWire
- 5 weeks ago - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment - GlobeNewsWire
- 6 weeks ago - Calidi Biotherapeutics Announces Shareholder Letter from CEO - GlobeNewsWire
- 3 months ago - Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire